)
Edge10 Jul 2026
Inside Take-Two: The Grand Anticipation
The story of how Take-Two Interactive built the empire behind Grand Theft Auto, Red Dead Redemption, and one of gaming's largest mobile portfolios.
Huadong Medicine Co
Huadong Medicine Co (000963) investor relations material
Huadong Medicine Co Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2026 earnings summary8 Jul, 2026
Executive summary
Operating revenue for Q1 2026 reached RMB 11.18 billion, up 4.17% year-over-year and 2.15% sequentially from Q4 2025.
Net profit attributable to shareholders was RMB 1.00 billion, a 9.56% increase year-over-year, with adjusted net profit (excluding non-recurring items) up 10.30% to RMB 990 million, a historical high for the period.
The company focused on innovation, new product launches, and expanding market presence, driving strong growth in innovative product revenue.
Financial highlights
Operating revenue: RMB 11.18 billion, up 4.17% year-over-year.
Net profit attributable to shareholders: RMB 1.00 billion, up 9.56% year-over-year.
Adjusted net profit (excluding non-recurring items): RMB 990 million, up 10.30% year-over-year.
Basic and diluted EPS: RMB 0.5715, up 9.40% and 9.63% year-over-year, respectively.
Net cash flow from operating activities: -RMB 852 million, a 2.35% decrease year-over-year.
Outlook and guidance
External competition and policy volatility are expected to intensify in 2026, but the company remains committed to its innovation-driven strategy and operational upgrades.
Continued focus on R&D, clinical studies, and commercialization of innovative products to drive future growth.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Huadong Medicine Co
- Revenue up 4.07% to RMB 43.61B; innovative product sales surged 64.2% year-over-year.000963
Q4 20258 Jul 2026 - 2023 revenue and profit hit record highs, fueled by innovation and global expansion.000963Q4 202322 Dec 2025
- Net profit surged 23.72% to ¥3.51 billion on record revenue and robust R&D investment.000963Q4 202422 Dec 2025
- Revenue and profit rose on strong pharma growth, while aesthetics rebounded sequentially.000963Q1 202522 Dec 2025
- Q3 2025 saw 4.53% revenue growth and 7.71% net profit growth year-over-year.000963Q3 202522 Dec 2025
- Revenue and net profit rose, driven by innovation and robust segment performance.000963Q2 202522 Oct 2025
- Record H1 2024 profit and revenue growth, with robust R&D and strong interim dividend.000963Q2 202413 Jun 2025
- Net profit rose 17.05% year-over-year on steady revenue and robust pharma segment growth.000963Q3 202413 Jun 2025
- Net profit rose 14.18% on steady revenue and robust growth in key business segments.000963Q1 202413 Jun 2025
Next Huadong Medicine Co earnings date
Q2 202627 Aug, 2026
Huadong Medicine Co
Next Huadong Medicine Co earnings date
Q2 202627 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage